• ABOUT
  • TEAM
  • SERVICES
  • RESULTS
  • MEDIA & EVENTS

AstraZeneca Divests Antimalarials to Alliance Pharmaceuticals; Plexus Ventures Assisted AstraZeneca with this Transaction

by plexusventures_h3tnl0 | Aug 2, 2012 | Uncategorized

London, United Kingdom — Plexus Ventures is pleased to announce the successful completion of a divestment project. Plexus provided transaction services to AstraZeneca UK Limited in the divesture of three of the company’s antimalarial brands — PaludrineTM,...

Klaus Welzel, Senior Consultant – Frankfurt, has passed away

by plexusventures_h3tnl0 | Jul 23, 2012 | Uncategorized

Los Angeles, California — The Plexus Ventures team is saddened to announce that Klaus Welzel PhD., Senior Consultant – Frankfurt, passed away on July 23, 2012. Klaus is survived by his wife Renate, three adult children, and two grandchildren. The funeral was...

Plexus Ventures Successfully Concludes Product Divestment Assignment

by plexusventures_h3tnl0 | Jun 24, 2011 | Uncategorized

Los Angeles, California — Plexus Ventures is pleased to announce the successful completion of its most recent divestment project. Plexus provided professional services to Novartis Consumer Health in the divestiture of an OTC product having European sales to a...

Novartis Divests Product to Recordati, Plexus Ventures Facilitated Deal

by plexusventures_h3tnl0 | Jan 27, 2011 | Uncategorized

Plexus Ventures Concludes Product Divestment Assignment Los Angeles, California — Plexus Ventures is pleased to announce the successful completion of its most recent divestment project. Plexus provided professional services to Novartis Consumer Health in the...
« Older Entries
Next Entries »

Recent Posts

  • Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer
  • Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs
  • Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody
  • Celon Pharma enters agreement with Zydus Lifesciences Ltd.
  • Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses

Recent Comments

    Collaborating with clients to grow their businesses; committing our experience, resources and time to their success.

    Business Builders in Healthcare

    Contact Us
    • Follow

    About Us

    Our Team

    Areas of Expertise

    Project Portfolio

    What’s Trending